SUBSCRIBE
SUBSCRIBE
News   Policy

Elan Corporation PLC To Settle Zonegran Investigation For $204M

July 16, 2010 | 
1 min read

BusinessWeek -- Irish drugmaker Elan Corp. PLC said Thursday it agreed to pay $203.5 million to settle investigations into sales and marketing practices related to the epilepsy drug Zonegran.

Legal Europe
MORE ON THIS TOPIC
Sign outside BioNTech's building in Germany
Breast cancer
BioNTech Builds Case for PD-L1/VEGF Bispecific With Promising Breast Cancer Data
December 11, 2024
 · 
2 min read
 · 
Tristan Manalac
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
December 9, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: AstraZeneca building in Gothenburg/iStoc
China
AstraZeneca Names New International Operations Lead Amid Probe on China Exec
December 5, 2024
 · 
3 min read
 · 
Tristan Manalac
Pictured: A scientist works behind an FDA sign/Tay
FDA Tracker
AstraZeneca, Merus Notch Cancer Approvals
December 5, 2024
 · 
212 min read
 · 
BioSpace Editorial Staff